Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 2
1958 3
1959 6
1960 9
1961 7
1962 13
1963 8
1964 19
1965 3
1966 19
1967 30
1968 14
1969 52
1970 81
1971 113
1972 183
1973 212
1974 220
1975 199
1976 109
1977 95
1978 104
1979 104
1980 101
1981 115
1982 94
1983 102
1984 130
1985 118
1986 109
1987 129
1988 139
1989 162
1990 119
1991 267
1992 503
1993 581
1994 646
1995 617
1996 695
1997 679
1998 631
1999 675
2000 724
2001 823
2002 803
2003 870
2004 873
2005 820
2006 968
2007 929
2008 1114
2009 1071
2010 1307
2011 1388
2012 1379
2013 1334
2014 1456
2015 1526
2016 1399
2017 1449
2018 1501
2019 1528
2020 1768
2021 1505
2022 976
2023 854
2024 1194
2025 408

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35,183 results

Results by year

Filters applied: . Clear all
Page 1
Coronavirus Disease-2019 in the Immunocompromised Host.
Bertini CD Jr, Khawaja F, Sheshadri A. Bertini CD Jr, et al. Clin Chest Med. 2023 Jun;44(2):395-406. doi: 10.1016/j.ccm.2022.11.012. Epub 2022 Nov 22. Clin Chest Med. 2023. PMID: 37085228 Free PMC article. Review.
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates than immunocompetent patients. ...This review focuses on the specific impact of COVID-19 in immunocompromised patients and the gaps i …
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates …
Diagnosis of severe respiratory infections in immunocompromised patients.
Azoulay E, Russell L, Van de Louw A, Metaxa V, Bauer P, Povoa P, Montero JG, Loeches IM, Mehta S, Puxty K, Schellongowski P, Rello J, Mokart D, Lemiale V, Mirouse A; Nine-i Investigators. Azoulay E, et al. Intensive Care Med. 2020 Feb;46(2):298-314. doi: 10.1007/s00134-019-05906-5. Epub 2020 Feb 7. Intensive Care Med. 2020. PMID: 32034433 Free PMC article. Review.
An increasing number of critically ill patients are immunocompromised. Acute hypoxemic respiratory failure (ARF), chiefly due to pulmonary infection, is the leading reason for ICU admission. ...Invasive fungal infections (Aspergillus, Mucorales, and Pneumocystis jirovecii) …
An increasing number of critically ill patients are immunocompromised. Acute hypoxemic respiratory failure (ARF), chiefly due to pulm …
Pneumonia in the Immunocompromised Host.
Murali S, Marks A, Heeger A, Dako F, Febbo J. Murali S, et al. Semin Roentgenol. 2022 Jan;57(1):90-104. doi: 10.1053/j.ro.2021.10.009. Epub 2021 Nov 3. Semin Roentgenol. 2022. PMID: 35090713
Pneumonia in the immunocompromised host can be devastating and can result from both common and opportunistic organisms. This paper examines the imaging findings in mostly opportunistic organisms which cause pneumonia in the immunocompromised host. Some …
Pneumonia in the immunocompromised host can be devastating and can result from both common and opportunistic organisms. This p …
Coronavirus Disease-2019 in the Immunocompromised Host.
Bertini CD Jr, Khawaja F, Sheshadri A. Bertini CD Jr, et al. Infect Dis Clin North Am. 2024 Mar;38(1):213-228. doi: 10.1016/j.idc.2023.12.007. Infect Dis Clin North Am. 2024. PMID: 38280765 Review.
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates than immunocompetent patients. ...This review focuses on the specific impact of COVID-19 in immunocompromised patients and the gaps i …
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates …
Coronavirus Disease-2019 in the Immunocompromised Host.
Bertini CD Jr, Khawaja F, Sheshadri A. Bertini CD Jr, et al. Rheum Dis Clin North Am. 2025 Feb;51(1):123-138. doi: 10.1016/j.rdc.2024.09.002. Rheum Dis Clin North Am. 2025. PMID: 39550101 Review.
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates than immunocompetent patients. ...This review focuses on the specific impact of COVID-19 in immunocompromised patients and the gaps i …
Immunocompromised patients who develop COVID-19 have a more severe illness, higher hospitalization rates, and higher mortality rates …
Humanized Mice for the Study of Immuno-Oncology.
De La Rochere P, Guil-Luna S, Decaudin D, Azar G, Sidhu SS, Piaggio E. De La Rochere P, et al. Trends Immunol. 2018 Sep;39(9):748-763. doi: 10.1016/j.it.2018.07.001. Epub 2018 Aug 2. Trends Immunol. 2018. PMID: 30077656 Review.
Epidemiology, treatment and prevention of herpes zoster: A comprehensive review.
Koshy E, Mengting L, Kumar H, Jianbo W. Koshy E, et al. Indian J Dermatol Venereol Leprol. 2018 May-Jun;84(3):251-262. doi: 10.4103/ijdvl.IJDVL_1021_16. Indian J Dermatol Venereol Leprol. 2018. PMID: 29516900 Free article. Review.
It is seen more commonly among individuals aged 50 years, those with immunocompromised status, and those on immunosuppressant drugs. It is caused by a reactivation of varicella zoster virus infection. ...We cover the incidence of herpes zoster, gender distribution, seasona …
It is seen more commonly among individuals aged 50 years, those with immunocompromised status, and those on immunosuppressant drugs. …
35,183 results
You have reached the last available page of results. Please see the User Guide for more information.

Searches related to "immunocompromised host"